Mutual of America Capital Management LLC raised its position in shares of IMAX Co. (NYSE:IMAX – Free Report) by 22.2% in the third quarter, Holdings Channel reports. The fund owned 206,291 shares of the company’s stock after buying an additional 37,462 shares during the quarter. Mutual of America Capital Management LLC’s holdings in IMAX were worth $4,231,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. US Bancorp DE lifted its position in shares of IMAX by 23.4% during the 3rd quarter. US Bancorp DE now owns 7,656 shares of the company’s stock worth $157,000 after purchasing an additional 1,452 shares during the last quarter. Huntington National Bank acquired a new stake in shares of IMAX in the third quarter worth $34,000. Headlands Technologies LLC bought a new position in IMAX during the second quarter worth $35,000. Price T Rowe Associates Inc. MD boosted its holdings in IMAX by 19.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,082 shares of the company’s stock valued at $212,000 after purchasing an additional 2,153 shares during the period. Finally, nVerses Capital LLC acquired a new stake in IMAX in the 3rd quarter worth $70,000. 93.51% of the stock is owned by institutional investors and hedge funds.
IMAX Stock Performance
IMAX opened at $24.60 on Friday. The firm has a market cap of $1.30 billion, a price-to-earnings ratio of 55.90, a PEG ratio of 1.63 and a beta of 1.22. The firm’s 50-day simple moving average is $21.68 and its 200-day simple moving average is $19.43. IMAX Co. has a twelve month low of $13.20 and a twelve month high of $25.28.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their price objective on shares of IMAX from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Monday, October 14th. Barrington Research reaffirmed an “outperform” rating and issued a $24.00 price target on shares of IMAX in a report on Thursday, October 31st. Rosenblatt Securities reiterated a “buy” rating and issued a $28.00 price objective on shares of IMAX in a research report on Thursday, October 31st. Macquarie upped their target price on IMAX from $24.00 to $26.00 and gave the company an “outperform” rating in a research note on Friday, July 26th. Finally, Roth Mkm raised their target price on IMAX from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, IMAX currently has a consensus rating of “Moderate Buy” and an average target price of $24.22.
View Our Latest Analysis on IMAX
IMAX Company Profile
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Further Reading
- Five stocks we like better than IMAX
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Co. (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.